Panel’s Split Decision On Dyax HAE Drug Belies Consensus On Clinical Data
This article was originally published in The Pink Sheet Daily
Executive Summary
Advisory panel concerned with limited efficacy and safety data; members express uncertainty over standards for orphan drug approval.